These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 5850269

  • 1. Accentuation of the psychological effects of LSD-25 in normal subjects treated with reserpine.
    Resnick O, Krus DM, Raskin M.
    Life Sci; 1965 Jul; 4(14):1433-7. PubMed ID: 5850269
    [No Abstract] [Full Text] [Related]

  • 2. Release of particulate norepinephrine by d-LSD-25 and reserpine.
    Sankar DV, Domjan M.
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):205-14. PubMed ID: 4686104
    [No Abstract] [Full Text] [Related]

  • 3. Vesicular and juxtavesicular serotonin: effects of lysergic acid diethylamide and reserpine.
    Halaris AE, Freedman DX.
    J Pharmacol Exp Ther; 1977 Dec; 203(3):575-86. PubMed ID: 925959
    [Abstract] [Full Text] [Related]

  • 4. [Effect of vagotomy and lysergic acid diethylamide (LSD) on ulcerogenic action of phenylbutazone and reserpine in rats with regard to the role of 5-hydroxytryptamine (author's transl)].
    Kohút A, Nicák A.
    Bratisl Lek Listy; 1977 Sep; 68(3):336-43. PubMed ID: 912454
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of psychotomimetic compounds on human pseudocholinesterase.
    FRIED GH, ANTOPOL W.
    J Appl Physiol; 1957 Jul; 11(1):25-8. PubMed ID: 13462913
    [No Abstract] [Full Text] [Related]

  • 11. Effects of LSD on synthesis and release of 5-HT in rat brain slices.
    Hamon M, Bourgoin S, Jagger J, Glowinski J.
    Brain Res; 1974 Apr 05; 69(2):265-80. PubMed ID: 4823095
    [No Abstract] [Full Text] [Related]

  • 12. Potentiation of bufotenine-like syndrome induced by diethyltryptamine in reserpinized rats.
    Khazan N, Hirsch A, Sulman FG.
    Electroencephalogr Clin Neurophysiol; 1967 Jun 05; 22(6):589. PubMed ID: 4165027
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evidence of catecholamine mediation in the "aberrant" behaviour induced by lysergic acid diethylamide (LSD) in the rat.
    Dixon AK.
    Experientia; 1968 Jul 15; 24(7):743-7. PubMed ID: 4387561
    [No Abstract] [Full Text] [Related]

  • 17. Interaction of delta9-tetrahydrocannabinol with reserpine, phenobarbital, and LSD-25 on plasma and adrenal corticosterone.
    Mitra G, Poddar MK, Ghosh JJ.
    Toxicol Appl Pharmacol; 1977 Dec 15; 42(3):505-12. PubMed ID: 601793
    [No Abstract] [Full Text] [Related]

  • 18. Reserpine suppression of dorsal raphe neuronal firing: mediation by adrenergic system.
    Baraban JM, Wang RY, Aghajanian G.
    Eur J Pharmacol; 1978 Nov 01; 52(1):27-36. PubMed ID: 214312
    [No Abstract] [Full Text] [Related]

  • 19. Antagonism of beta-phenylethylamine derivatives and serotonin blocking drugs upon serotonin, tryptamine and reserpine behavioral depression in mice.
    Saavedra JM, Fischer E.
    Arzneimittelforschung; 1970 Jul 01; 20(7):952-7. PubMed ID: 5536068
    [No Abstract] [Full Text] [Related]

  • 20. Effect of lysergic acid diethylamide on larval growth.
    SANKAR DV, KOPELMAN A, SCHILDER P, GOLD E.
    Nature; 1960 Jul 09; 187():153-4. PubMed ID: 14441518
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.